tiprankstipranks
Trending News
More News >
Alexandria Real Estate Equities (ARE)
NYSE:ARE

Alexandria Equities (ARE) AI Stock Analysis

Compare
1,159 Followers

Top Page

ARE

Alexandria Equities

(NYSE:ARE)

Select Model
Select Model
Select Model
Neutral 59 (OpenAI - 5.2)
Rating:59Neutral
Price Target:
$61.00
▲(10.29% Upside)
The score is held back primarily by weakened financial performance (notably the 2025 earnings reversal) and cautious near-term operating outlook from the earnings call (occupancy/NOI pressure and impairments). Offsetting factors include solid underlying cash generation, constructive near-term technical momentum, and an attractive dividend yield.
Positive Factors
Operating cash generation
Stable, positive operating cash flow provides a durable cash-earnings base that funds dividends, development and dispositions without relying on equity issuance. This buffers the business through leasing cycles and supports capital allocation flexibility despite episodic FCF volatility.
Liquidity & debt maturity
High liquidity and an exceptionally long debt maturity profile materially reduce near-term refinancing risk and give management flexibility to time dispositions and leasing recoveries. This structural balance-sheet strength supports execution of repositioning without forced asset sales.
Leasing backlog and specialized demand
A sizable signed-lease backlog that will begin contributing mid‑2026 provides predictable forward cash flow and illustrates sustained tenant demand for life-science campuses. Converting this backlog reduces reliance on spot leasing and helps stabilize same‑property NOI over the medium term.
Negative Factors
Earnings quality deterioration
A sharp swing to a large net loss and slowing revenue growth reflect weakened earnings quality that can erode retained capital and dividend coverage. Persistently depressed profitability would pressure FFO conversion, restrict reinvestment, and could force more aggressive asset dispositions.
Significant impairments
Large, concentrated impairments—much tied to land—indicate structural write-downs in expected development value and reduce net asset value. These losses can constrain future development economics, lower recurring earnings potential, and increase scrutiny of project underwriting going forward.
Near-term occupancy and NOI headwinds
Concentrated lease expirations and tenant wind‑downs create structural downtime risk and elevated concession usage, pressuring same‑property NOI and cash rents. Recovery depends on re-leasing and market demand improving in H2 2026, so near‑term cash flows and leverage metrics face persistent pressure.

Alexandria Equities (ARE) vs. SPDR S&P 500 ETF (SPY)

Alexandria Equities Business Overview & Revenue Model

Company DescriptionAlexandria Real Estate Equities, Inc. (NYSE:ARE), an S&P 500® urban office real estate investment trust (REIT), is the first, longest-tenured, and pioneering owner, operator, and developer uniquely focused on collaborative life science, technology, and agtech campuses in AAA innovation cluster locations, with a total market capitalization of $31.9 billion as of December 31, 2020, and an asset base in North America of 49.7 million square feet (SF). The asset base in North America includes 31.9 million RSF of operating properties and 3.3 million RSF of Class A properties undergoing construction, 7.1 million RSF of near-term and intermediate-term development and redevelopment projects, and 7.4 million SF of future development projects. Founded in 1994, Alexandria pioneered this niche and has since established a significant market presence in key locations, including Greater Boston, San Francisco, New York City, San Diego, Seattle, Maryland, and Research Triangle. Alexandria has a longstanding and proven track record of developing Class A properties clustered in urban life science, technology, and agtech campuses that provide our innovative tenants with highly dynamic and collaborative environments that enhance their ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science, technology, and agtech companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.
How the Company Makes MoneyAlexandria Equities generates revenue primarily through leasing its properties to life science and technology tenants. The company operates on a long-term lease model, which provides a steady stream of rental income. Additionally, it enhances its revenue by engaging in property development and redevelopment projects, which can yield higher rental rates upon completion. The company also benefits from the increasing demand for specialized lab and office spaces, driven by growth in the biotech and pharmaceutical sectors. Significant partnerships with leading academic institutions and research organizations further bolster its revenue potential, as these collaborations often lead to increased occupancy rates and long-term leases.

Alexandria Equities Key Performance Indicators (KPIs)

Any
Any
Revenue By Segment
Revenue By Segment
Breaks down revenue by different business segments, highlighting which areas are driving growth and profitability, and where there might be challenges.
Chart InsightsAlexandria Equities has shown consistent growth in Same Properties Rental Income, with recent quarters maintaining strong performance, indicating robust demand in their core properties. Non-Same Properties Rental Income has been more volatile, suggesting potential challenges in newer or non-core assets. Tenant Recoveries have steadily increased, reflecting effective cost pass-through to tenants. The 'Other' category, while minor, shows sporadic spikes, hinting at occasional one-off gains. Overall, the company appears to be capitalizing on stable core assets while navigating variability in newer segments.
Data provided by:The Fly

Alexandria Equities Earnings Call Summary

Earnings Call Date:Jan 26, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:Apr 27, 2026
Earnings Call Sentiment Neutral
The call described strong execution on balance sheet management, sizable Q4 dispositions ($1.5B), notable leasing momentum (1.2M sqft in Q4 and nearly 900k sqft signed to commence in Q3 2026), substantial G&A savings (30%, $51.3M), healthy liquidity ($5.3B) and a robust adjusted EBITDA margin (70%). Offsetting these positives were material Q4 impairments ($1.45B), same-property NOI declines (-6% Q4, -3.5% FY), elevated free rent and near-term occupancy headwinds driven by 1.2M sqft of lease expirations and an assumed ~$6M per quarter rent reduction tied to tenant wind-downs. Management expects a Q1 2026 dip in occupancy and a temporary leverage increase, with recovery anticipated in the back half of 2026 as dispositions and signed-lease commencements occur. Overall, the company conveyed operational resilience and strong liquidity while also acknowledging significant near-term earnings and asset-value pressures that create uncertainty into 2026.
Q4-2025 Updates
Positive Updates
Strong Q4 Dispositions and Execution
Completed $1.5 billion of dispositions in Q4 across 26 transactions, helping achieve the company’s leverage target and advance the 2026 non-core disposition program.
Robust Q4 Leasing Volume
Total leasing volume of 1.2 million rentable square feet in Q4 (highest quarter in the last year), up 14% versus the prior 4-quarter average and up 10% versus the prior 8-quarter average; 393,000 rentable square feet of vacant space leased in Q4 — almost double the 5-quarter quarterly average.
Backlog of Signed Leases Driving Future Revenue
Nearly 900,000 rentable square feet of signed leases (about 2.5% of the portfolio) are expected to commence on average in Q3 2026 and generate approximately $52 million of incremental annual rental revenue.
FFO and Earnings Execution
FFO per share diluted as adjusted was $2.16 for Q4 2025 and $9.01 for the full year 2025, which tracked at the midpoint of prior guidance; reaffirmed 2026 FFO guidance and the Q4'26 trough expectation of $1.40 to $1.60 per share.
Operating Margin and Cost Savings
Adjusted EBITDA margin of 70% for Q4 2025; achieved $51.3 million of G&A savings in 2025 (a 30% reduction versus prior year) and reported G&A as ~5.6% of NOI — about half the S&P 500 REIT average.
Strong Balance Sheet and Liquidity
Liquidity of $5.3 billion, longest average remaining debt maturity among S&P 500 REITs at just over 12 years, and modest leverage at 5.7x net debt to adjusted EBITDA (Q4 annualized); reiterated 4Q'26 leverage guidance of 5.6x to 6.2x.
Reduced Capitalized Interest Outlook
Guidance for capitalized interest in 2026 of $250 million, down 24% from 2025, driven by dispositions and evaluations to pause or sell certain projects under construction.
Progress on Repositioning Non-Income Assets
Reduced non-income-producing assets as a percentage of gross assets from 20% at end of 2024 to 17% at end of 2025 and expects continued declines through 2026; disposition program expected to include 65%-75% non-core assets and land of the $2.9 billion midpoint guidance.
Negative Updates
Same-Property NOI Declines
Same-property NOI decreased 6% in Q4 2025 (down 1.7% on a cash basis) and was down 3.5% for full-year 2025 (up 0.9% on a cash basis), reflecting lower occupancy and market pressures.
Large Impairments Recognized
Recognized share of impairments totaling $1.45 billion in Q4 2025 (≈90% previously disclosed); 50%-60% of the impairments related to land, and two largest impairments represented 37% of the total (including 88 Bluxome St. and Gateway campus).
Occupancy Pressure and Near-Term Downtime
End-of-2025 occupancy was 90.9% (up 30 bps from prior quarter), but management expects occupancy to dip in Q1 2026 driven by 1.2 million rentable square feet of key lease expirations with expected downtime; guidance reiterates year-end 2026 occupancy range of 87.7% to 89.3%.
Revenue Headwinds from Tenant Wind-Downs and Lease Termination
Guidance assumes approximately $6 million reduction in rent per quarter starting Q1 2026 related to potential tenant wind-downs; terminated a lease for ~171,000 rentable square feet in South San Francisco (annual revenue ~$11.4M) — re-leased but new lease expected to commence in H2 2026, creating temporary vacancy.
Market Leasing Pressure on Free Rent and Rates
Free rent and rental rate changes on renewals and new releases were under pressure in Q4; free rent has elevated and was used as a primary tool to win deals, indicating weakening near-term cash collection versus contractual rent.
Lower Venture Realized Gains in Q4
Realized gains from venture investments were $21 million in Q4, down from an approximate $32 million quarterly average for the prior three quarters; 2026 realized gains guidance reiterated at $60M-$90M (midpoint ≈$19M per quarter).
Temporary Leverage Increase Expected in Q1 2026
Management expects net debt to annualized adjusted EBITDA to temporarily increase by about 1.0x to 1.5x on a quarterly annualized basis in Q1 2026 due to reduced quarterly adjusted EBITDA, with improvement expected later as dispositions close.
Regulatory and Industry Uncertainty
Company highlighted the fifth year of a life science bear market and significant regulatory uncertainty (FDA leadership departures and policy volatility), which has slowed investor and tenant decision-making and lengthened leasing cycles.
Company Guidance
The company reiterated its 2026 financial framework: year‑end occupancy guidance of 87.7%–89.3% (while expecting an occupancy dip in Q1 2026 driven by ~1.2M rsf of key lease expirations—~60% of which expired in mid‑January—and recovery in H2), Q4’26 FFO/share of $1.40–$1.60 (treated as the trough), same‑property NOI guidance centered around ±8.5% at the midpoint, and dispositions/sales of partial interest guidance with a $2.9B midpoint (with ~65%–75% of that amount expected to be non‑core assets and land, and most closings weighted to Q2–Q4 with a third‑quarter weighted average). Key operating and capital assumptions include ~900k rsf of signed leases (≈2.5% of the portfolio) expected to commence in Q3’26 generating ~$52M of incremental annual rent; an assumed ~$6M/quarter revenue headwind from tenant wind‑downs starting Q1’26; a 2%–3% assumed benefit from assets sold/HFS in H2’26; capitalized interest guidance of $250M for 2026 (down 24% YoY); realized investment gains of $60M–$90M for 2026 (≈$19M/quarter at midpoint); liquidity of $5.3B; Q4’25 net debt/annualized adjusted EBITDA of 5.7x and reiterated Q4’26 target of 5.6x–6.2x (with Q1’26 quarterly‑annualized leverage expected to be temporarily ~1.0–1.5x higher); and continued cost discipline after $51.3M (30%) G&A savings in 2025, with those savings versus 2024 expected to be roughly half in 2026.

Alexandria Equities Financial Statement Overview

Summary
Cash flow is the key support (consistently positive operating cash flow and generally positive free cash flow with a strong 2025 rebound). However, the income statement deteriorated sharply with a major 2025 net loss and decelerating revenue growth, and balance-sheet leverage trends are harder to interpret due to the reported 2025 debt step-change.
Income Statement
44
Neutral
Revenue has grown over the period, but growth has decelerated materially (2022: ~22% to 2024: ~7%), and 2025 shows only ~1% growth. Profitability has deteriorated sharply: after positive net margins in 2020–2024, 2025 swung to a large loss (net margin ~-48%), which overwhelms the otherwise strong gross profit profile (~70% gross margin). Overall, the income statement reflects weakening earnings quality and a major downside break in the most recent year.
Balance Sheet
58
Neutral
The balance sheet was moderately levered through 2020–2024 with debt-to-equity generally in the ~0.54–0.71 range, which is reasonable for a REIT, and equity has remained sizable. However, profitability on equity has been low and volatile, turning negative in 2025 alongside the net loss. Notably, 2025 reports zero total debt (and a zero debt-to-equity ratio), a major step-change versus prior years that is supportive if accurate, but it also introduces comparability/consistency risk when assessing leverage trends.
Cash Flow
71
Positive
Operating cash flow is consistently positive and relatively stable (~$0.9B–$1.6B across the period), providing a solid core cash earnings base. Free cash flow is generally positive and closely tracks operating cash flow, with strong growth in 2022 and 2023 and a modest decline in 2024; 2025 rebounds strongly (reported free cash flow growth ~2.8x). The main weakness is volatility, including a very large negative free cash flow in 2021, which signals episodic cash demands despite otherwise healthy cash generation.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue2.97B3.05B2.84B2.58B2.11B
Gross Profit2.05B2.14B1.98B1.79B1.48B
EBITDA360.45M1.90B1.45B1.77B1.62B
Net Income-1.43B322.95M103.64M521.66M571.25M
Balance Sheet
Total Assets34.08B37.53B36.77B35.52B30.22B
Cash, Cash Equivalents and Short-Term Investments549.06M552.15M618.19M825.19M361.35M
Total Debt12.76B12.75B11.70B10.57B9.23B
Total Liabilities14.93B15.13B14.15B12.84B11.19B
Stockholders Equity15.47B17.89B18.47B18.97B16.19B
Cash Flow
Free Cash Flow1.41B1.50B1.63B1.29B-6.32B
Operating Cash Flow1.41B1.50B1.63B1.29B1.01B
Investing Cash Flow527.59M-1.51B-2.50B-5.08B-7.11B
Financing Cash Flow-1.95B-93.31M674.16M4.23B5.92B

Alexandria Equities Technical Analysis

Technical Analysis Sentiment
Positive
Last Price55.31
Price Trends
50DMA
51.70
Positive
100DMA
61.27
Negative
200DMA
67.59
Negative
Market Momentum
MACD
0.76
Positive
RSI
53.18
Neutral
STOCH
19.44
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ARE, the sentiment is Positive. The current price of 55.31 is below the 20-day moving average (MA) of 55.77, above the 50-day MA of 51.70, and below the 200-day MA of 67.59, indicating a neutral trend. The MACD of 0.76 indicates Positive momentum. The RSI at 53.18 is Neutral, neither overbought nor oversold. The STOCH value of 19.44 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ARE.

Alexandria Equities Risk Analysis

Alexandria Equities disclosed 11 risk factors in its most recent earnings report. Alexandria Equities reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Alexandria Equities Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
$4.09B12.655.94%5.75%0.77%62.58%
71
Outperform
$7.03B23.5510.01%4.30%0.06%8.88%
65
Neutral
$2.17B12.193.79%4.94%3.15%1.96%
63
Neutral
$4.37B73.241.26%5.08%16.38%3.60%
59
Neutral
$9.59B-8.62%10.90%-0.76%-250.60%
58
Neutral
$6.38B7.2515.97%2.24%2.41%
52
Neutral
$11.10B36.025.24%5.26%2.54%-155.17%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ARE
Alexandria Equities
55.31
-36.80
-39.95%
BXP
BXP
63.73
-5.94
-8.52%
CUZ
Cousins Properties
25.99
-3.31
-11.30%
KRC
Kilroy Realty
34.28
-1.26
-3.55%
VNO
Vornado Realty
30.57
-11.71
-27.70%
CDP
COPT Defense Properties
31.10
2.33
8.09%

Alexandria Equities Corporate Events

Business Operations and StrategyExecutive/Board Changes
Alexandria Equities boosts performance-based pay, promotes co-president
Positive
Jan 12, 2026

On January 9, 2026, Alexandria Real Estate Equities amended Executive Chairman Joel S. Marcus’s long-term incentive compensation for the 2025 fiscal year so that 100% of his $3.6 million target equity award is now subject to performance-based vesting rather than a mix of time- and performance-based vesting, raising the maximum potential value to $5.4 million but making all shares contingent on meeting corporate performance criteria. The company also elevated John Hart Cole to Co-President & Co-Regional Market Director – Seattle, effective January 1, 2026, building on his prior capital markets and strategic operations roles, with only a salary increase tied to the promotion, underscoring Alexandria’s emphasis on performance-linked executive pay and strengthening leadership in a key regional market.

The most recent analyst rating on (ARE) stock is a Hold with a $55.00 price target. To see the full list of analyst forecasts on Alexandria Equities stock, see the ARE Stock Forecast page.

Executive/Board ChangesStock Buyback
Alexandria Equities Announces New Stock Repurchase Program
Neutral
Dec 8, 2025

On December 3, 2025, Daniel J. Ryan, Co-President and Regional Market Director for San Diego at Alexandria Real Estate Equities, Inc., resigned from his positions due to personal and health reasons, effective December 31, 2025. Ryan had been with the company since 2010, and his departure was acknowledged with gratitude by the Board of Directors for his strategic contributions. Additionally, on December 5, 2025, Alexandria’s Board approved a new common stock repurchase program, replacing the existing authorization set to expire at the end of 2025. The new program allows for the repurchase of up to $500 million of common stock until December 31, 2026, with the company opting to fund these repurchases on a leverage-neutral basis through operating activities and real estate transactions.

The most recent analyst rating on (ARE) stock is a Hold with a $48.00 price target. To see the full list of analyst forecasts on Alexandria Equities stock, see the ARE Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 28, 2026